
Cellgen is a molecular diagnostics company focused on precision medicine, developing an innovative immuno-oncology companion diagnostic platform. Their technology enables in-house blood tests to assess immune system health and predict patient responses to immuno-oncology therapies. By leveraging RNA-based diagnostics, Cellgen aims to provide comprehensive insights into patient health, ensuring that the right individuals receive the appropriate treatments. With a strong team and a unique approach, Cellgen is positioned to capitalize on the growing market for personalized medicine, enhancing patient outcomes and reducing treatment costs.

Cellgen is a molecular diagnostics company focused on precision medicine, developing an innovative immuno-oncology companion diagnostic platform. Their technology enables in-house blood tests to assess immune system health and predict patient responses to immuno-oncology therapies. By leveraging RNA-based diagnostics, Cellgen aims to provide comprehensive insights into patient health, ensuring that the right individuals receive the appropriate treatments. With a strong team and a unique approach, Cellgen is positioned to capitalize on the growing market for personalized medicine, enhancing patient outcomes and reducing treatment costs.